-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Intraclonal Myeloma Heterogeneity Through Single Cell Sequencing

Program: Scientific Workshops @ ASH
Session: The Molecular and Immunobiology of Disease Evolution and Progression in Multiple Myeloma
Thursday, December 3, 2020, 7:42 AM-8:22 AM

Maximilian Merz, MD

Roswell Park Comprehensive Cancer Center Institute, Buffalo, NY

Disclosures: Merz: Amgen, BMS, Celgene, Takeda: Honoraria.